Inotek Pharmaceuticals Corp (NASDAQ:ITEK): James A. Silverman’s Opaleye Management filed an amended 13D.
You can check out Opaleye Management’s latest holdings and filings here.
Please follow Opaleye Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Opaleye Management or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Opaleye Management Inc||0||1,555,000||0||1,555,000||9||11 5.76%|
Page 1 of 7 – SEC Filing
SECURITIES AND EXCHANGE COMMISSION
the Securities Exchange Act of 1934
of Class of Securities)
of Event Which Requires Filing of this Statement)
the appropriate box to designate the rule pursuant to which this Schedule is filed:
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).